Section Review: Biologicals & Immunologicals: Complex carbohydrates in development as human pharmaceuticals
- 3 March 1994
- journal article
- Published by Taylor & Francis in Expert Opinion on Investigational Drugs
- Vol. 3 (3) , 223-239
- https://doi.org/10.1517/13543784.3.3.223
Abstract
There are many actual and potential pharmaceutical uses of complex carbohydrates. These include: direct use as therapeutic pharmaceutical agents; indirect use as pharmaceutical excipients and carriers; use as diagnostic agents, whether for ex vivo testing or in vivo imaging; oligosaccharides as vaccines; and nutritionals. In addition, complex carbohydrates may be employed in medical devices and other medical products. This overview will focus attention on anti-adhesive oligosaccharides under investigation in the therapy of inflammatory and infectious diseases as well as cancer, glycan immune adjuvants, heparin-derived agents for cardiovascular indications, cyclic oligosaccharides as amphiphilic carrier agents and immunogenic oligosaccharides as cancer vaccine components. In addition to reviewing pertinent preclinical research that points toward potential novel therapeutic agents, emphasis will be placed on compounds currently in clinical development. Chemical issues that affect the manufacture of therapeutic complex carbohydrates will also be considered.Keywords
This publication has 76 references indexed in Scilit:
- Attachment of Helicobacter pylori to Human Gastric Epithelium Mediated by Blood Group AntigensScience, 1993
- Inhibitory effects of a bacteria‐derived sulfated polysaccharide against basic fibroblast growth factor‐induced endothelial cell growth and chemotaxisJournal of Cellular Physiology, 1993
- Engineering galactose-binding activity into a C-type mannose-binding proteinNature, 1992
- Helicobacter pylori: Its Role in DiseaseClinical Infectious Diseases, 1992
- Fucoidan is a non-anticoagulant inhibitor of intimal hyperplasiaBiochemical and Biophysical Research Communications, 1992
- Chlamydia trachomatis and chlamydia pneumoniae bind specifically to phosphatidylethanolamine in HeLa cells and to galnacβ1-4galβ1-4glc sequences found in asialo-GM1 and asialo-GM2Biochemical and Biophysical Research Communications, 1991
- THE HEPARIN-BINDING (FIBROBLAST) GROWTH FACTOR FAMILY OF PROTEINSAnnual Review of Biochemistry, 1989
- GLYCOBIOLOGYAnnual Review of Biochemistry, 1988
- Enhancement of allo-resposiveness of human lymphocytes by acemannan (CarrisynTM)International Journal of Immunopharmacology, 1988
- A novel approach to the study of glycolipid receptors for virusesFEBS Letters, 1984